Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above.
This report contains market size and forecasts of Age Related Macular Degeneration Drugs in global, including the following market information:
- Global Age Related Macular Degeneration Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Age Related Macular Degeneration Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Age Related Macular Degeneration Drugs companies in 2021 (%)
The global Age Related Macular Degeneration Drugs market was valued at 7949.4 million in 2021 and is projected to reach US$ 11590 million by 2028, at a CAGR of 5.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lucentis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Age Related Macular Degeneration Drugs include Novartis, Bayer Healthcare, Roche, Neurotech Pharmaceuticals, Regeneron Pharmaceuticals and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Age Related Macular Degeneration Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Age Related Macular Degeneration Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Age Related Macular Degeneration Drugs Market Segment Percentages, by Type, 2021 (%)
- Lucentis
- Eylea
- Avastin
- Squalamine
- Conercept
- Lampalizamab
- Others
Global Age Related Macular Degeneration Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Age Related Macular Degeneration Drugs Market Segment Percentages, by Application, 2021 (%)
- 50-60 Years Old
- 60-70 Years Old
- Others
Global Age Related Macular Degeneration Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Age Related Macular Degeneration Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Age Related Macular Degeneration Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Age Related Macular Degeneration Drugs revenues share in global market, 2021 (%)
- Key companies Age Related Macular Degeneration Drugs sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Age Related Macular Degeneration Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis
- Bayer Healthcare
- Roche
- Neurotech Pharmaceuticals
- Regeneron Pharmaceuticals
- Allergan
